Welcome to P K Kelkar Library, Online Public Access Catalogue (OPAC)

Colorectal Cancer (Record no. 503304)

000 -LEADER
fixed length control field 03371nam a22004455i 4500
001 - CONTROL NUMBER
control field 978-1-59745-215-1
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20161121230736.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 100301s2007 xxu| s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781597452151
-- 978-1-59745-215-1
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/978-1-59745-215-1
Source of number or code doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC254-282
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJCL
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED062000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.994
Edition number 23
245 10 - TITLE STATEMENT
Title Colorectal Cancer
Medium [electronic resource] :
Remainder of title Evidence-Based Chemotherapy Strategies /
Statement of responsibility, etc. edited by Maurie Markman, Leonard B. Saltz.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Totowa, NJ :
Name of producer, publisher, distributor, manufacturer Humana Press,
Date of production, publication, distribution, manufacture, or copyright notice 2007.
300 ## - PHYSICAL DESCRIPTION
Other physical details online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Encoding format PDF
Source rda
490 1# - SERIES STATEMENT
Series statement Current Clinical Oncology
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Molecular Biology of Colon Cancer -- Chemoprevention of Colorectal Cancer -- Colorectal Cancer Screening and Surveillance -- Cytotoxic Chemotherapy for Metastatic Colorectal Cancer -- Integration of Antiangiogenic Strategies Into Colorectal Cancer Treatment -- The Role of EGFR Inhibition in Colorectal Cancer -- Second-Line Strategies in the Treatment of Patients With Metastatic Colorectal Cancer -- Adjuvant Chemotherapy for Colon Cancer -- Management of Locally Advanced Rectal Cancer -- Rationale for Adjuvant and Neoadjuvant Chemotherapy in the Resection of Liver Metastases -- Percutaneous Radiofrequency Ablation in the Management of Patients With Colorectal Cancer -- Colorectal Cancer Imaging -- Nursing Issues in Colorectal Cancer Chemotherapy -- Pain Management in the Colorectal Cancer Patient -- Novel Agents and New Paradigms for Colorectal Cancer Beyond EGFR and VEGF.
520 ## - SUMMARY, ETC.
Summary, etc. Management options for patients with colorectal cancer have undergone d- matic changes over the past decade. Whereas at the start of 1996 only one drug, 5-Fluorouracil, was available for the treatment of this disease, a mere 10 yr later, six drugs are licensed for use in colorectal cancer, and others are in the late phases of clinical development. Likewise, surgical and ablative options, as well as an array of supportive medications, have shown substantial progress and undergone a dramatic proliferation over the past decade. With the increased number of therapeutic options from which to choose, the clinician is better able to offer effective therapy to the patient with colorectal cancer. The clinician is challenged, however, to keep up with the rapidly changing landscape and the rapidly emerging data that shape the options for treatment today and tom- row. In this text, leaders in the management of colorectal cancer review the current literature that has led us to where we are today. Critical evaluations of the data are offered, and evidence-based recommendations are made.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Medicine.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oncology.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Medicine & Public Health.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oncology.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Markman, Maurie.
Relator term editor.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Saltz, Leonard B.
Relator term editor.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9781588297518
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Current Clinical Oncology
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-1-59745-215-1
912 ## -
-- ZDB-2-SME
Holdings
Withdrawn status Lost status Damaged status Not for loan Permanent Location Current Location Date acquired Barcode Date last seen Price effective from Koha item type
        PK Kelkar Library, IIT Kanpur PK Kelkar Library, IIT Kanpur 2016-11-21 EBK3591 2016-11-21 2016-11-21 E books

Powered by Koha